Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Landgren

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Lakartidningen|October 20, 1971
[Experience with gonorrhea treatment in 1969]B M Landgren, L Molin, B Nyström
Lakartidningen|December 13, 1995
[Connection between levonorgestrel-IUD and GAS (Group A Streptococcus) sepsis? Reliable risk assessment is not yet possible]I Milsom, B M Landgren, K Alestig
Contraception|May 1, 1984
IUD-induced changes in cervical secretion content of albumin, IgG and complement C3cL Fleetwood, B M Landgren, P Eneroth
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|June 1, 1996
Risk for ovulation in women taking a low-dose oral contraceptive (Microgynon) when receiving antibacterial treatment with a fluoroquinolone (ofloxacin)G Csemiczky, C Alvendal, B M Landgren
Maturitas|October 1, 1988
Endometrial and vaginal response to three different oestrogen preparations administered by the transdermal and oral routesE Johannisson, B M Landgren, E Diczfalusy
Gynecologic and Obstetric Investigation|January 1, 1986
Quantitation of human cervical mucin during consecutive days and hourly during one day at midcycleL Fleetwood, B M Landgren, P Eneroth
Maturitas|April 2, 1998
Urogenital and vasomotor symptoms in relation to menopausal status and the use of hormone replacement therapy (HRT) in healthy women during transition to menopauseB Larson, A Collins, B M Landgren
Gynecologic and Obstetric Investigation|January 1, 1984
A method for isolation, characterization, and quantitation of soluble proteins in uterine cervical secretionL Fleetwood, B M Landgren, P Eneroth
Contraception|March 1, 1981
Hormonal effects of the 300 microgram norethisterone (NET) minipill. 3. Comparison of the short-term (2nd month) and medium-term (6th month) effects in 21 subjectsB M Landgren, S Lager, E Diczfalusy
Human Reproduction (Oxford, England)|August 1, 1989
Repeated mid-cycle tests of in-vitro sperm penetration (Kremer tests) in healthy women during three menstrual cyclesB Jonsson, B M Landgren, P Eneroth
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Lakartidningen|October 20, 1971
[Experience with gonorrhea treatment in 1969]B M Landgren, L Molin, B Nyström
Lakartidningen|December 13, 1995
[Connection between levonorgestrel-IUD and GAS (Group A Streptococcus) sepsis? Reliable risk assessment is not yet possible]I Milsom, B M Landgren, K Alestig
Contraception|May 1, 1984
IUD-induced changes in cervical secretion content of albumin, IgG and complement C3cL Fleetwood, B M Landgren, P Eneroth
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|June 1, 1996
Risk for ovulation in women taking a low-dose oral contraceptive (Microgynon) when receiving antibacterial treatment with a fluoroquinolone (ofloxacin)G Csemiczky, C Alvendal, B M Landgren
Maturitas|October 1, 1988
Endometrial and vaginal response to three different oestrogen preparations administered by the transdermal and oral routesE Johannisson, B M Landgren, E Diczfalusy
Gynecologic and Obstetric Investigation|January 1, 1986
Quantitation of human cervical mucin during consecutive days and hourly during one day at midcycleL Fleetwood, B M Landgren, P Eneroth
Maturitas|April 2, 1998
Urogenital and vasomotor symptoms in relation to menopausal status and the use of hormone replacement therapy (HRT) in healthy women during transition to menopauseB Larson, A Collins, B M Landgren
Gynecologic and Obstetric Investigation|January 1, 1984
A method for isolation, characterization, and quantitation of soluble proteins in uterine cervical secretionL Fleetwood, B M Landgren, P Eneroth
Contraception|March 1, 1981
Hormonal effects of the 300 microgram norethisterone (NET) minipill. 3. Comparison of the short-term (2nd month) and medium-term (6th month) effects in 21 subjectsB M Landgren, S Lager, E Diczfalusy
Human Reproduction (Oxford, England)|August 1, 1989
Repeated mid-cycle tests of in-vitro sperm penetration (Kremer tests) in healthy women during three menstrual cyclesB Jonsson, B M Landgren, P Eneroth
Pageof 13